Allworth Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Allworth Financial’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-505	Closed	-$447	–	3341
2022 Q4	$447	Sell	505 -1,875	-79%	-$2.49K	﹤0.01%	2663
2022 Q3	$4K	Buy	+2,380	New	+$5.4K	﹤0.01%	1994
2022 Q2	–	Sell	-1,000	Closed	-$2K	–	2957
2022 Q1	$2K	Hold	1,000	–	–	﹤0.01%	1854
2021 Q4	$5K	Sell	1,000 -100	-9%	-$621	﹤0.01%	1576
2021 Q3	$8K	Buy	1,100 +1,000	+1,000%	+$8.48K	﹤0.01%	1421
2021 Q2	$1K	Hold	100	–	–	﹤0.01%	1519
2021 Q1	$1K	Hold	100	–	–	﹤0.01%	1455
2020 Q4	$1K	Buy	+100	New	+$803	﹤0.01%	1317

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return